475 related articles for article (PubMed ID: 11558835)
1. Telmisartan: a review of its use in hypertension.
Sharpe M; Jarvis B; Goa KL
Drugs; 2001; 61(10):1501-29. PubMed ID: 11558835
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of telmisartan, a selective AT1 receptor antagonist, compared with enalapril in elderly patients with primary hypertension. TEES Study Group.
Karlberg BE; Lins LE; Hermansson K
J Hypertens; 1999 Feb; 17(2):293-302. PubMed ID: 10067800
[TBL] [Abstract][Full Text] [Related]
3. Comparison of telmisartan with lisinopril in patients with mild-to-moderate hypertension.
Neutel JM; Frishman WH; Oparil S; Papademitriou V; Guthrie G
Am J Ther; 1999 May; 6(3):161-6. PubMed ID: 10423659
[TBL] [Abstract][Full Text] [Related]
4. Telmisartan/hydrochlorothiazide: in the treatment of essential hypertension.
Fenton C; Keating GM; Scott LJ
Drugs; 2003; 63(19):2013-26; discussion 2027-8. PubMed ID: 12962518
[TBL] [Abstract][Full Text] [Related]
5. Dose response and safety of telmisartan in patients with mild to moderate hypertension.
Smith DH; Matzek KM; Kempthorne-Rawson J
J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1380-90. PubMed ID: 11185637
[TBL] [Abstract][Full Text] [Related]
6. Comparison of 26-week efficacy and tolerability of telmisartan and atenolol, in combination with hydrochlorothiazide as required, in the treatment of mild to moderate hypertension: a randomized, multicenter study.
Freytag F; Schelling A; Meinicke T; Deichsel G;
Clin Ther; 2001 Jan; 23(1):108-23. PubMed ID: 11219471
[TBL] [Abstract][Full Text] [Related]
7. Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: impact on the early morning period.
White WB; Lacourciere Y; Davidai G
Am J Hypertens; 2004 Apr; 17(4):347-53. PubMed ID: 15062889
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of fixed-dose combinations of telmisartan plus HCTZ compared with losartan plus HCTZ in patients with essential hypertension.
Lacourcière Y; Gil-Extremera B; Mueller O; Byrne M; Williams L
Int J Clin Pract; 2003 May; 57(4):273-9. PubMed ID: 12800457
[TBL] [Abstract][Full Text] [Related]
9. Telmisartan.
McClellan KJ; Markham A
Drugs; 1998 Dec; 56(6):1039-44; discussion 1045-6. PubMed ID: 9878991
[TBL] [Abstract][Full Text] [Related]
10. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
Lacourcière Y; Neutel JM; Schumacher H
Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
[TBL] [Abstract][Full Text] [Related]
11. Effects of the angiotensin II receptor blockers telmisartan versus valsartan in combination with hydrochlorothiazide: a large, confirmatory trial.
White WB; Murwin D; Chrysant SG; Koval SE; Davidai G; Guthrie R
Blood Press Monit; 2008 Feb; 13(1):21-7. PubMed ID: 18199920
[TBL] [Abstract][Full Text] [Related]
12. Comparative effects of telmisartan in the treatment of hypertension.
White WB
J Clin Hypertens (Greenwich); 2002; 4(4 Suppl 1):20-5. PubMed ID: 12147925
[TBL] [Abstract][Full Text] [Related]
13. Treatment of hypertension with an angiotensin II-receptor antagonist compared with an angiotensin-converting enzyme inhibitor: a review of clinical studies of telmisartan and enalapril.
Smith DH
Clin Ther; 2002 Oct; 24(10):1484-501. PubMed ID: 12462282
[TBL] [Abstract][Full Text] [Related]
14. Optimal dosing characteristics of the angiotensin II receptor antagonist telmisartan.
Meredith PA
Am J Cardiol; 1999 Jul; 84(2A):7K-12K. PubMed ID: 10437738
[TBL] [Abstract][Full Text] [Related]
15. Telmisartan plus amlodipine in patients with moderate or severe hypertension: results from a subgroup analysis of a randomized, placebo-controlled, parallel-group, 4 x 4 factorial study.
Littlejohn TW; Majul CR; Olvera R; Seeber M; Kobe M; Guthrie R; Oigman W;
Postgrad Med; 2009 Mar; 121(2):5-14. PubMed ID: 19332958
[TBL] [Abstract][Full Text] [Related]
16. ABPM comparison of the antihypertensive profiles of the selective angiotensin II receptor antagonists telmisartan and losartan in patients with mild-to-moderate hypertension.
Mallion J; Siche J; Lacourcière Y
J Hum Hypertens; 1999 Oct; 13(10):657-64. PubMed ID: 10516734
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the efficacy and duration of action of telmisartan, amlodipine and ramipril in patients with confirmed ambulatory hypertension.
Poirier L; de Champlain J; Larochelle P; Lamarre-Cliche M; Lacourcière Y
Blood Press Monit; 2004 Oct; 9(5):231-6. PubMed ID: 15472494
[TBL] [Abstract][Full Text] [Related]
18. Blood pressure-lowering and antiproteinuric effect of switching from high-dose angiotensin receptor blockers to normal-dose telmisartan and low-dose hydrochlorothiazide in hypertensive patients with chronic kidney disease.
Abe M; Okada K; Maruyama T; Matsumoto S; Matsumoto K
Int J Clin Pharmacol Ther; 2010 Mar; 48(3):206-13. PubMed ID: 20197015
[TBL] [Abstract][Full Text] [Related]
19. Telmisartan/Hydrochlorothiazide: a review of its use as fixed-dose combinations in essential hypertension.
Plosker GL; White WB
Drugs; 2008; 68(13):1877-99. PubMed ID: 18729541
[TBL] [Abstract][Full Text] [Related]
20. Use of ambulatory blood pressure monitoring to evaluate the selective angiotensin II receptor antagonist, telmisartan, and other antihypertensive drugs.
Neutel JM
Blood Press Monit; 2000; 5 Suppl 1():S35-40. PubMed ID: 10904241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
